Brind.

David King was appointed to a board in July 2025, while Lance V. Berberian held executive roles at LabCorp and Quest Diagnostics.

1 report, 0 independent Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

David King was appointed to a board in July 2025, while Lance V. Berberian held executive roles at LabCorp and Quest Diagnostics.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet